ABUS icon

Arbutus Biopharma

55 hedge funds and large institutions have $212M invested in Arbutus Biopharma in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.4M
Puts
$864K
Net Calls
Net Calls Change

Top Buyers

1 +$4.62M
2 +$2.59M
3 +$2.56M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.42M
5
Axa
Axa
France
+$2.29M

Top Sellers

1 -$20.2M
2 -$11.5M
3 -$9.2M
4
Invesco
Invesco
Georgia
-$5.1M
5
AC
Ascend Capital
California
-$4.39M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$380K
27
$313K
28
$253K
29
$243K
30
$226K
31
$208K
32
$201K
33
$193K
34
$174K
35
$157K
36
$155K
37
$152K
38
$137K
39
$122K
40
$117K
41
$103K
42
$71K
43
$60K
44
$46K
45
$32K
46
$32K
47
$31K
48
$17K
49
$9K
50
$5K